Most-engaged members lost 25.2% more weight at week 40 and persisted 2.2x longer on medication program than least-engaged members using the Noom app, demonstrating the benefits of combining GLP-1 medication with Nooms GLP-1 Companion behavior-change program PRINCETON, N.J., February 4, 2026 Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Nooms leading GLP-1 Companion app tend to lose more weight and stay on a medication program longer
The role of lifestyle changing to improve the semen quality in patients with varicocele
They may differ in efficacy, safety, risk, and side-effect profiles from commercially available or FDA-approved drugs
42, 43, 44 Finally, in a prospective study in 952 postmenopausal women, an impairment in endothelial function was shown to be an efficient independent predictor of the development of arterial hypertension during a follow-up of 3.6 years